• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Chinese expert consensus on clinical performance and quality measures for adults with acute ST-segment elevation myocardial infarction].

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Nov 24;46(11):849-856. doi: 10.3760/cma.j.issn.0253-3758.2018.11.007.

DOI:10.3760/cma.j.issn.0253-3758.2018.11.007
PMID:30462972
Abstract
摘要

相似文献

1
[Chinese expert consensus on clinical performance and quality measures for adults with acute ST-segment elevation myocardial infarction].《成人急性ST段抬高型心肌梗死临床诊疗与质量控制中国专家共识》
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Nov 24;46(11):849-856. doi: 10.3760/cma.j.issn.0253-3758.2018.11.007.
2
2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2017年美国心脏协会/美国心脏病学会关于ST段抬高型和非ST段抬高型心肌梗死成人患者的临床性能和质量指标：美国心脏病学会/美国心脏协会性能指标特别工作组报告
Circ Cardiovasc Qual Outcomes. 2017 Oct;10(10). doi: 10.1161/HCQ.0000000000000032.
3
Impact of time of presentation on process performance and outcomes in ST-segment-elevation myocardial infarction: a report from the American Heart Association: Mission Lifeline program.就诊时间对ST段抬高型心肌梗死治疗过程及结局的影响：美国心脏协会“生命线使命”项目报告
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):656-63. doi: 10.1161/CIRCOUTCOMES.113.000740. Epub 2014 Jul 29.
4
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后的ST段恢复情况及预后：急性心肌梗死中佩昔单抗评估（APEX-AMI）试验的见解
Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8.
5
[The Chinese expert consensus on reteplase thrombolytic therapy for acute ST-segment elevation myocardial infarction].《急性ST段抬高型心肌梗死瑞替普酶溶栓治疗中国专家共识》
Zhonghua Nei Ke Za Zhi. 2016 Jul 1;55(7):572-7. doi: 10.3760/cma.j.issn.0578-1426.2016.07.022.
6
Ultra-Sensitive Copeptin and Cardiac Troponin in Diagnosing Non-ST-Segment Elevation Acute Coronary Syndromes--The COPACS Study.超敏 C 肽和心肌肌钙蛋白在诊断非 ST 段抬高型急性冠状动脉综合征中的作用——COPACS 研究。
Am J Med. 2016 Jan;129(1):105-14. doi: 10.1016/j.amjmed.2015.06.033. Epub 2015 Jul 11.
7
ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction).美国心脏病学会/美国心脏协会ST段抬高型和非ST段抬高型心肌梗死成人患者临床绩效指标：美国心脏病学会/美国心脏协会绩效指标特别工作组（制定ST段抬高型和非ST段抬高型心肌梗死绩效指标的写作委员会）报告
J Am Coll Cardiol. 2006 Jan 3;47(1):236-65. doi: 10.1016/j.jacc.2005.10.020.
8
Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction.白细胞介素-1基因多态性患者的幽门螺杆菌血清阳性与ST段抬高型心肌梗死显著相关。
PLoS One. 2016 Nov 10;11(11):e0166240. doi: 10.1371/journal.pone.0166240. eCollection 2016.
9
Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events.非ST段抬高型心肌梗死患者在急诊科停留时间延长与对美国心脏病学会/美国心脏协会管理指南的依从性较差以及不良事件增加有关。
Ann Emerg Med. 2007 Nov;50(5):489-96. doi: 10.1016/j.annemergmed.2007.03.033. Epub 2007 Jun 20.
10
Quality of care for myocardial infarction at academic and nonacademic hospitals.学术医院和非学术医院心肌梗死的护理质量。
Am J Med. 2012 Apr;125(4):365-73. doi: 10.1016/j.amjmed.2011.11.015.

引用本文的文献

1
Development and validation of a nomogram model for predicting the risk of pre-hospital delay in patients with acute myocardial infarction.急性心肌梗死患者院前延误风险预测列线图模型的构建与验证
World J Cardiol. 2024 Feb 26;16(2):80-91. doi: 10.4330/wjc.v16.i2.80.
2
Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study.中国心力衰竭患者的性能指标与临床结局之间的关联：HERO研究结果
Clin Cardiol. 2024 Feb;47(2):e24233. doi: 10.1002/clc.24233.
3
ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction.
沙库巴曲缬沙坦与血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂在心肌梗死后降低心血管事件的比较。
ESC Heart Fail. 2021 Dec;8(6):4607-4616. doi: 10.1002/ehf2.13644. Epub 2021 Oct 19.